Help Us Protect Access to Sexual and Reproductive Health Care Today!
Feb 25
Written by Judy Lipshutz, MSW, RN Values Clarification (VC) is a process of self-reflection that encourages honest and respectful conversations about how our values impact the care we provide. We all have values, opinions, biases, and identities; and we come from different generations, cultures, races, and religions. Developing self-awareness about how our values impact our…
Feb 18
The Reproductive Health Access Project has finished updating the Medical Eligibility Criteria for Initiating Contraception based on the 2024 CDC Medical Eligibility Criteria (MEC) and Selected Practice Recommendations (SPR) for Contraceptive Use. This is a reference tool for clinicians who want to check a patient’s medical eligibility for initiating various forms of contraception as they…
Feb 05
Clinical policy and procedure for the progestin injection (Depo-Provera).
Feb 04
A tool for health care providers who want to check a patient’s medical eligibility for various forms of contraception as they relate to absolute and relative contraindications.
Jan 30
A consent form that can be used with patients before inserting an IUD.
Jan 30
Explains the basics of how to use the progestin intrauterine device (IUD).
Jan 29
This presentation is designed for those working in primary care settings to introduce medication abortion to staff and help facilitate conversation about providing MAB services at your organization. It covers reproductive justice, the benefits of providing MAB in primary care, common myths about abortion, the basic process of a medication abortion, and more. It is…
Jan 29
A step-by-step guide to order mifepristone in the U.S.
Jan 28
Written by Silpa Srinivasulu, MPH After the Dobbs v Jackson Women’s Health decision overturned Roe v. Wade in June 2022, nearly half of US states banned or severely restricted access to abortion care. To date, 12 states ban abortion in nearly all circumstances and six restrict abortion at 12 weeks of pregnancy or less. While…
Jan 21
Written by Sabina Kapkayeva Pharm.D. candidate and Regina Ginzburg, Pharm.D., CDCES, BC-ADM Glucagon-like peptide-1 (GLP-1 agonists) and glucose-dependent insulinotropic peptides (GIP) are increasingly being used in the management of diabetes and/or for weight loss. Several GLP-1 agonist medications available today are known to have interactions with oral hormonal contraceptives, but not through the usual pharmacokinetic…